Inhibition of MYC by the SMARCB1 tumor suppressor
April M. Weissmiller(Middle Tennessee State University), William P. Tansey(Vanderbilt University)
Cited by 89
Related Papers
Interaction of the oncoprotein transcription factor MYC with its chromatin cofactor WDR5 is essential for tumor maintenance
|Proceedings of the National Academy of Sciences|2019|122
Drugging the “Undruggable” MYCN Oncogenic Transcription Factor: Overcoming Previous Obstacles to Impact Childhood Cancers
|Cancer Research|2021|70
WIN site inhibition disrupts a subset of WDR5 function
|Scientific Reports|2022|38